Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for YCBD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 8.212M
March 31, 2026 9.285M
December 31, 2025 9.008M
September 30, 2025 7.226M
June 30, 2025 6.110M
March 31, 2025 0.6658M
December 31, 2024 1.782M
September 30, 2024 1.963M
June 30, 2024 3.028M
March 31, 2024 3.087M
December 31, 2023 7.037M
September 30, 2023 9.031M
June 30, 2023 25.73M
March 31, 2023 25.79M
December 31, 2022 26.59M
September 30, 2022 31.42M
June 30, 2022 46.60M
March 31, 2022 80.02M
Date Value
December 31, 2021 84.40M
September 30, 2021 103.14M
June 30, 2021 89.28M
March 31, 2021 85.88M
December 31, 2020 85.72M
September 30, 2020 79.18M
June 30, 2020 83.58M
March 31, 2020 92.16M
December 31, 2019 55.52M
September 30, 2019 37.60M
June 30, 2019 25.38M
March 31, 2019 -14.69M
December 31, 2018 16.79M
September 30, 2018 12.61M
June 30, 2018 13.81M
March 31, 2018 14.16M
December 31, 2017 13.35M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Tilray Brands, Inc. 1.614B
Organogenesis Holdings, Inc. 288.13M
Guardian Pharmacy Services, Inc. 245.61M
Nektar Therapeutics 903.12M
Elite Pharmaceuticals, Inc. 104.83M

Shareholders Equity (Quarterly) Related Metrics